No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
BDH Industries Limited specializes in the development and manufacture of therapeutic pharmaceutical products. Its extensive portfolio of medicines includes fentanyl citrate injection, acetaminophen oral solution, both tablet and injectable forms of paracetamol, benzyl benzoate application, praziquantel, mebendazole, thioridazine available as an oral solution and in tablet form, and haloperidol injection. The company was established in 1935 and is headquartered in Mumbai, India.
www.bdhind.comNo one on the platform currently holds BDH.BO.
No tracked institution reports a position in BDH.BO as of their last filing.
No one on the platform has traded BDH.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BDH.BOBDH Industries Limited | $500.00 | -1.01% | $2.9B | — |
| AMBALALSA.BOAmbalal Sarabhai Enterprises Limited | $39.40 | +1.99% | $3.0B | — |
| CORALAB.BOCoral Laboratories Limited | $574.00 | +1.49% | $2.1B | — |
| NATCAPSUQ.BONatural Capsules Limited | $174.00 | -4.03% | $1.8B | — |
| NURECA.BONureca Limited | $334.10 | +2.48% | $3.3B | — |
| NURECA.NSNureca Limited | $338.30 | +5.00% | $3.4B | — |
| OXYGENTAPH.BOOxygenta Pharmaceutical Ltd. | $52.13 | -2.45% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry